The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but

Po-Lin Tseng1,2, Chih-Wei Chen3,4,5, Keng-Hsun Hu6

  • 1Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 302, Taiwan.

Oncotarget
|May 4, 2018
PubMed

Insights

Silencing hexokinase 1 (HK1) in cancer cells alters energy metabolism, promoting tumor growth and metastasis. However, HK1-silenced cells become more vulnerable to 2-deoxyglucose (2-DG) treatment, suggesting targeted therapies.

Area of Science:

  • Cancer Biology
  • Metabolic Reprogramming
  • Tumorigenesis

Background:

  • Malignant tumors exhibit altered energy metabolism, primarily glycolysis (Warburg effect), for adenosine triphosphate (ATP) production.
  • Understanding these metabolic shifts is crucial for developing effective anti-cancer therapeutics.
  • Hexokinase (HK) enzymes are key regulators of glycolysis.

Purpose of the Study:

  • To investigate the role of attenuating glycolytic activity by silencing hexokinase (HK) isozymes HK1 and HK2 in tumor progression.
  • To explore the impact of HK1 and HK2 modulation on cancer cell metabolism, phenotype, and therapeutic susceptibility.

Main Methods:

  • Examined the effects of silencing hexokinase (HK) isozymes HK1 and HK2 in human cancer cells, specifically cervical carcinoma.
  • Utilized in vitro and in vivo analyses to assess tumor growth, metastasis, and phenotypic changes (epithelial-mesenchymal transition).
  • Analyzed cellular energy metabolism, including aerobic respiration, glycolysis, ATP generation, and key enzyme expression levels (HK1, HK2, lactate dehydrogenase 1, citrate synthase).

Main Results:

  • Silencing HK1, but not HK2, induced an epithelial-mesenchymal transition (EMT) phenotype, accelerating tumor growth and metastasis.
  • HK1 knockdown disrupted aerobic respiration, increased glycolysis, and enhanced glucose dependency without affecting ATP levels.
  • HK1-silenced cells showed increased susceptibility to 2-deoxyglucose (2-DG) induced proliferation inhibition.

Conclusions:

  • Silencing HK1 significantly alters cancer cell energy metabolism and promotes malignancy via EMT, while increasing sensitivity to 2-DG.
  • The study highlights an inverse correlation between HK1 and HK2 expression in cancer cells.
  • Results suggest that glycolytic inhibitors like 2-DG may be effective for cancers with elevated glycolytic activity, specifically those influenced by HK1.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.8K
Enzymes and Activation Energy01:13

Enzymes and Activation Energy

The activation energy (or free energy of activation), abbreviated as Ea, is the small amount of energy input necessary for all chemical reactions to occur. During chemical reactions, certain chemical bonds break, and new ones form. For example, when a glucose molecule breaks down, bonds between the molecule's carbon atoms break. Since these are energy-storing bonds, they release energy when broken. However, the molecule must be somewhat contorted to get into a state that allows the bonds to...
23.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.3K
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
95.1K
Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
172.0K
Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
17.4K